share_log

InMed Pharmaceuticals Shares Are Trading Higher After the Company Announced It Was Granted U.S. Patent US 12083229 B2 16/611837 for 'Ocular Drug Delivery Formulation'

InMed Pharmaceuticals Shares Are Trading Higher After the Company Announced It Was Granted U.S. Patent US 12083229 B2 16/611837 for 'Ocular Drug Delivery Formulation'

inmed pharmaceuticals股價上漲,因該公司宣佈獲得了美國專利US 12083229 B2 16/611837,用於「眼部藥物給藥配方」。
Benzinga ·  09/10 16:21

InMed Pharmaceuticals Shares Are Trading Higher After the Company Announced It Was Granted U.S. Patent US 12083229 B2 16/611837 for 'Ocular Drug Delivery Formulation'

inmed pharmaceuticals股價上漲,因該公司宣佈獲得了美國專利US 12083229 B2 16/611837,用於「眼部藥物給藥配方」。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論